# EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)

> **NCT02816736** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 365 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** LCZ696
- **DRUG:** valsartan
- **DRUG:** LCZ696 placebo
- **DRUG:** valsartan placebo

## Key facts

- **NCT ID:** NCT02816736
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-02
- **Primary completion:** 2020-09-15
- **Final completion:** 2020-09-29
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2021-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02816736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02816736, "EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02816736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*